Loading...
XNYS
TMO
Market cap217bUSD
Dec 05, Last price  
572.77USD
1D
-0.43%
1Q
16.27%
Jan 2017
305.93%
Name

Thermo Fisher Scientific Inc

Chart & Performance

D1W1MN
XNYS:TMO chart
P/E
34.27
P/S
5.06
EPS
16.71
Div Yield, %
0.20%
Shrs. gr., 5y
-1.01%
Rev. gr., 5y
10.92%
Revenues
42.88b
+0.05%
2,633,027,0003,791,617,0009,746,400,00010,498,000,00010,109,700,00010,788,700,00011,725,900,00012,509,900,00013,090,300,00016,889,600,00016,965,400,00018,274,100,00020,918,000,00024,358,000,00025,542,000,00032,218,000,00039,211,000,00044,915,000,00042,857,000,00042,879,000,000
Net income
6.34b
+5.67%
223,218,000168,935,000761,100,000994,200,000850,300,0001,035,600,0001,329,900,0001,177,900,0001,273,300,0001,894,400,0001,975,400,0002,021,800,0002,225,000,0002,938,000,0003,696,000,0006,375,000,0007,725,000,0006,950,000,0005,995,000,0006,335,000,000
CFO
8.67b
+3.10%
270,913,000405,654,0001,483,500,0001,420,200,0001,659,200,0001,497,800,0001,691,000,0002,039,500,0002,010,700,0002,619,600,0002,816,900,0003,156,300,0004,005,000,0004,543,000,0004,973,000,0008,289,000,0009,543,000,0009,154,000,0008,406,000,0008,667,000,000
Dividend
Sep 13, 20240.39 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
IPO date
Aug 27, 1980
Employees
130,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT